A Brand New Network
for Accelerated TPD Drug
Welcome to the Targeted Protein Degradation: Searchlight network
Built by the TPD Drug Development community for the TPD Drug Development community
Membership allows you to plug into a TPD-specific network of peers to identify and solve unexpected common challenges, work in a facilitated, structured but boundaryless way throughout the year to identify critical strategies and avoid costly mistakes. Members benefit from timely access to vital new thinking to help clarify thoughts and solidify ideas, offering a safe space, encouraging meaningful discussion around the pre-competitive questions to impact crucial TPD decision-making, potentially saving millions of development dollars.
Don’t miss out on the opportunity to be part of these critical conversations…
"Transitioning from animals to human models in the progress of TPD drugs through the clinic"
"The development of molecular glues compared to PROTACs"
"Knowing what new class of targets have the greatest potential for TPD drug development"
Join your peers today and be part of a global community of like-minded individuals
For more information on what’s included as part of the Targeted Protein Degradation: Searchlight membership, please download the membership brochure.
Here’s what you’ll learn more about:
- The unique mission and purpose of the network
- What membership includes
- How the quarterly cornerstone meetings work
- How bespoke value delivery works
- How we deliver demonstrable value to you
- Annual member investment
The feedback from members speaks for itself…
Anja Giese, VP Medicinal Chemistry, Bayer
“Success stories get presented at conferences but comparing notes and experiences around what didn’t work and getting ideas & input around specific questions is where the real value lies. This network offers a rare and vital chance for us to get exactly that insight”
Zhihua Sui, Chief Scientific Officer, Proteovant
“This network is worthwhile because it facilitates community connection and scientific exchange to find answers to the toughest questions together – benefiting our community and our patients.”
Amine Sadok, Director of Head Platform Biology, Monte Rosa
“Usually, we hear about the 1% of things that worked, this network presents the golden opportunity to hear about the 99% of things that didn’t.”
For more reviews about Targeted Protein Degradation: Searchlight membership, head to our testimonials page and hear directly from our members about why they've joined.
Leverage diverse experiences
Apply first-in-class and best-in-class science and learn about what hasn’t worked as well as what has
Save time and money
Avoid costly mistakes with timely insights and access to vital unpublished information
Make valuable connections
Tap into a ready-made collaborative working group to help solve common challenges together
Who qualifies for TPD Drug Development: Searchlight?
Strategic TPD-focused leaders
Member companies are represented by one internal champion who has strategic oversight over its TPD program
Motivated to share
Members will require a collaborative mindset, focused on what can be shared rather than being defined by what can’t
Fully Invested, Value-added
Members are fully engaged in the TPD space who have value to add to the group as well as to gain from plugging in